Clinical Trial Update: Open-Source Artificial Pancreas System Use Among People With Type 1 Diabetes Mellitus in China

View source ↗

Summary

ClinicalTrials.gov entry indicates an open-source artificial pancreas system is currently recruiting in China for people with Type 1 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Snippet

Sponsor: Third Affiliated Hospital, Sun Yat-Sen University | Conditions: Type 1 Diabetes Mellitus | Status: RECRUITING